Articoli recenti
- VisMederi Recognized Among Top 300 Fastest-Growing Companies of 2023 by Financial Times and Statista
- New Collaborative Research between VisMederi Group and GVGH on Enteric Fever Published in Frontiers in Immunology
- New Publication: Advancing Vaccine Research with GVGH – A Novel Assay for Quantifying Anti-Vi IgG in Clinical Sera
- The first workshop involving Trialect and the Vismederi Foundation is underway!
- VisMederi Foundation at the Bright-Night 2024
Commenti recenti
No comments to show.
Archivi
- November 2024
- October 2024
- September 2024
- August 2024
- June 2024
- May 2024
- April 2024
- January 2024
- November 2023
- October 2023
- August 2023
- July 2023
- May 2023
- December 2022
- November 2022
- September 2022
- June 2022
- May 2022
- March 2022
- October 2021
- August 2018
- October 2017
- May 2017
- March 2017
- November 2016
- October 2016
- September 2016
- August 2016
- January 2016
- October 2015
- July 2015
- May 2015
- January 2015
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- November 2013
- September 2013
- April 2013